Abstract

De novo lipogenesis (DNL) is disrupted in a wide range of human disease. Thus, quantification of DNL may provide insight into mechanisms and guide interventions if it can be performed rapidly and noninvasively. DNL flux is commonly measured by 2H incorporation into fatty acids following deuterated water (2H2O) administration. However, the sensitivity of this approach is limited by the natural abundance of 13C, which masks detection of 2H by mass spectrometry. Here we report that high-resolution Orbitrap gas-chromatography mass-spectrometry resolves 2H and 13C fatty acid mass isotopomers, allowing DNL to be quantified using lower 2H2O doses and shorter experimental periods than previously possible. Serial measurements over 24-hrs in mice detects the nocturnal activation of DNL and matches a 3H-water method in mice with genetic activation of DNL. Most importantly, DNL is detected in overnight-fasted humans in less than an hour and is responsive to feeding during a 4-h study. Thus, 2H specific MS provides the ability to study DNL in settings that are currently impractical.

Fat synthesis is necessary for normal physiology, but its dysregulation contributes to the pathology of many diseases. Here, the authors report a high-resolution mass spectrometry approach that quantifies fat synthesis flux in humans and mice following a brief and low dose of deuterated water.

Details

Title
Measurement of lipogenic flux by deuterium resolved mass spectrometry
Author
Fu Xiaorong 1   VIAFID ORCID Logo  ; Deja Stanisław 2   VIAFID ORCID Logo  ; Fletcher, Justin A 3 ; Anderson, Norma N 1 ; Mizerska Monika 4 ; Vale Gonçalo 1 ; Browning, Jeffrey D 5 ; Horton, Jay D 6 ; McDonald, Jeffrey G 1   VIAFID ORCID Logo  ; Mitsche, Matthew A 1 ; Burgess, Shawn C 7   VIAFID ORCID Logo 

 Center for Human Nutrition, The University of Texas Southwestern Medical Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); The University of Texas Southwestern Medical Center, Department of Molecular Genetics, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 Center for Human Nutrition, The University of Texas Southwestern Medical Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); The University of Texas Southwestern Medical Center, Department of Biochemistry, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 Center for Human Nutrition, The University of Texas Southwestern Medical Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); The University of Texas Southwestern Medical Center, Department of Clinical Nutrition, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 Center for Human Nutrition, The University of Texas Southwestern Medical Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 The University of Texas Southwestern Medical Center, Department of Clinical Nutrition, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 Center for Human Nutrition, The University of Texas Southwestern Medical Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 Center for Human Nutrition, The University of Texas Southwestern Medical Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); The University of Texas Southwestern Medical Center, Department of Pharmacology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2542530030
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.